This item is not eligible for Amazon Prime, but millions of other items are. Join Amazon Prime today. Already a member? Sign in.


Digital Delivery
(How does this work?)
 

Introgen obtains patent for p53 targeted chemotherapy.(Introgen Therapeutics Inc.): An article from: BIOTECH Patent News
  
Publisher: learn how customers can search inside this book.

Introgen obtains patent for p53 targeted chemotherapy.(Introgen Therapeutics Inc.): An article from: BIOTECH Patent News [HTML] (Digital)

No customer reviews yet. Be the first.
List Price: $5.95
Price: $5.95
Available for download now.
Ships from and sold by Amazon.com.

Edition: e-document (Learn more)
Good Books Make Great Gifts
Save all season long on bestsellers, kids' books, holiday favorites and more in our Books Holiday Store.

Editorial Reviews

Product Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on October 1, 2002. The length of the article is 482 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Introgen obtains patent for p53 targeted chemotherapy.(Introgen Therapeutics Inc.)
Publication: BIOTECH Patent News (Newsletter)
Date: October 1, 2002
Publisher: Biotech Patent News
Volume: 16 Issue: 10

Distributed by Thomson Gale

Product Details

  • Format: HTML
  • Printable: Yes
  • Mac OS Compatible: Yes
  • Windows Compatible: Yes
  • Handheld Compatible: Yes
  • File Size: 4 KB
  • Publisher: Biotech Patent News (July 30, 2005)
  • Average Customer Review: No customer reviews yet. Be the first.
  • Required Free Software: Any web browser

Suggested Tags from Similar Products

( What's this?)
Be the first one to add a relevant tag (keyword that's strongly related to this product).